Editorial: Current concepts of cellular and biological drugs to modulate regulatory T cell activity in the clinic, volume II
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Frontiers in immunology. - 14 (2023) , 1221904, ISSN: 1664-3224
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2023
- Urheber
- DOI
-
10.3389/fimmu.2023.1221904
- URN
-
urn:nbn:de:bsz:25-freidok-2378744
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:52 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wenger, Valentin
- Zeiser, Robert
- Universität
Entstanden
- 2023
Ähnliche Objekte (12)
Advances in understanding the pathogenesis of graft‐versus‐host disease
Deciphering the role of the major histocompatibility complex, the intestinal microbiome and metabolites in the pathogenesis of acute graft-versus-host disease
The role of purine metabolites as DAMPs in acute graft-versus-host disease
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
NLRP3 inflammasome activation in cancer: a double-edged sword
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Chimeric antigen receptor T cells for acute myeloid leukemia
The role of MicroRNAs in myeloid cells during graft-versus-host disease
Kinase inhibition as treatment for acute and chronic graft-versus-host disease
Acute graft-versus-host disease, infections, vascular events and drug toxicities affecting the central nervous system
Immunotherapy in myeloproliferative diseases
Immunomodulatory therapies for the treatment of graft-versus-host disease
Advances in understanding the pathogenesis of graft‐versus‐host disease
Deciphering the role of the major histocompatibility complex, the intestinal microbiome and metabolites in the pathogenesis of acute graft-versus-host disease
The role of purine metabolites as DAMPs in acute graft-versus-host disease
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
NLRP3 inflammasome activation in cancer: a double-edged sword
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Chimeric antigen receptor T cells for acute myeloid leukemia
The role of MicroRNAs in myeloid cells during graft-versus-host disease
Kinase inhibition as treatment for acute and chronic graft-versus-host disease
Acute graft-versus-host disease, infections, vascular events and drug toxicities affecting the central nervous system
Immunotherapy in myeloproliferative diseases
Immunomodulatory therapies for the treatment of graft-versus-host disease
Advances in understanding the pathogenesis of graft‐versus‐host disease
Deciphering the role of the major histocompatibility complex, the intestinal microbiome and metabolites in the pathogenesis of acute graft-versus-host disease
The role of purine metabolites as DAMPs in acute graft-versus-host disease
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
NLRP3 inflammasome activation in cancer: a double-edged sword
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Chimeric antigen receptor T cells for acute myeloid leukemia
The role of MicroRNAs in myeloid cells during graft-versus-host disease
Kinase inhibition as treatment for acute and chronic graft-versus-host disease
Acute graft-versus-host disease, infections, vascular events and drug toxicities affecting the central nervous system
Immunotherapy in myeloproliferative diseases